Hope for the future..
Notably, RM-581 demonstrated superior antiproliferative activity in LAPC-4 cells compared to enzalutamide and abiraterone, two drugs that exhibited a synergistic effect in combination with RM-581.
Hope for the future..
Notably, RM-581 demonstrated superior antiproliferative activity in LAPC-4 cells compared to enzalutamide and abiraterone, two drugs that exhibited a synergistic effect in combination with RM-581.
Even if this is a good start, we are only at the lab rat stage. And I note that the article is published in an MDPI journal, which is "not top tier".